<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">N.N. Priorov Journal of Traumatology and Orthopedics</journal-id><journal-title-group><journal-title xml:lang="en">N.N. Priorov Journal of Traumatology and Orthopedics</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник травматологии и ортопедии им. Н.Н. Приорова</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-8678</issn><issn publication-format="electronic">2658-6738</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">677727</article-id><article-id pub-id-type="doi">10.17816/vto677727</article-id><article-id pub-id-type="edn">JRWARQ</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original study articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Antibacterial activity of amikacin-, cefotaxime-, and meropenem-impregnated bone cement discs against gram-negative bacteria <italic>Pseudomonas aeruginosa</italic> and <italic>Klebsiella pneumoniae</italic></article-title><trans-title-group xml:lang="ru"><trans-title>Антибактериальная активность амикацина, цефотаксима и меропенема, импрегнированных в диски на основе костного цемента, в отношении грамотрицательных бактерий <italic>Pseudomonas aeruginosa, Klebsiella pneumoniae</italic></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2012-3115</contrib-id><contrib-id contrib-id-type="spin">3039-5202</contrib-id><name-alternatives><name xml:lang="en"><surname>Shipitsyna</surname><given-names>Irina V.</given-names></name><name xml:lang="ru"><surname>Шипицына</surname><given-names>Ирина Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biology)</p></bio><bio xml:lang="ru"><p>канд. биол. наук</p></bio><email>IVSchimik@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2408-4352</contrib-id><contrib-id contrib-id-type="spin">1146-2236</contrib-id><name-alternatives><name xml:lang="en"><surname>Osipova</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Осипова</surname><given-names>Елена Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biology)</p></bio><bio xml:lang="ru"><p>канд. биол. наук</p></bio><email>E-V-OsipovA@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7434-1404</contrib-id><contrib-id contrib-id-type="spin">4266-8306</contrib-id><name-alternatives><name xml:lang="en"><surname>Shastov</surname><given-names>Alexander L.</given-names></name><name xml:lang="ru"><surname>Шастов</surname><given-names>Александр Леонидович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><email>alshastov@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8516-8571</contrib-id><contrib-id contrib-id-type="spin">9345-8300</contrib-id><name-alternatives><name xml:lang="en"><surname>Stogov</surname><given-names>Maksim V.</given-names></name><name xml:lang="ru"><surname>Стогов</surname><given-names>Максим Валерьевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Biology)</p></bio><bio xml:lang="ru"><p>д-р биол. наук</p></bio><email>stogo_off@list.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2602-2457</contrib-id><contrib-id contrib-id-type="spin">8521-4839</contrib-id><name-alternatives><name xml:lang="en"><surname>Sudnitsyn</surname><given-names>Anatoly S.</given-names></name><name xml:lang="ru"><surname>Судницын</surname><given-names>Анатолий Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><email>anatol_anatol@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Medical Research Center of Traumatology and Orthopedics named after Academician G.A. Ilizarov</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр травматологии и ортопедии им. академика Г.А. Илизарова</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2025-11-12" publication-format="electronic"><day>12</day><month>11</month><year>2025</year></pub-date><pub-date date-type="pub" iso-8601-date="2026-04-02" publication-format="electronic"><day>02</day><month>04</month><year>2026</year></pub-date><volume>33</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>104</fpage><lpage>112</lpage><history><date date-type="received" iso-8601-date="2025-03-26"><day>26</day><month>03</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-04-29"><day>29</day><month>04</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Эко-Вектор</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2027-04-02"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/0869-8678/article/view/677727">https://journals.eco-vector.com/0869-8678/article/view/677727</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND: </bold>There is an ongoing need to develop new antibiotic-loaded bone cement formulations, including those effective against resistant bacterial strains. Such formulations should create a local antibacterial environment capable of inhibiting bacterial growth and eliminating pathogens without inducing toxic reactions.</p> <p><bold>AIM: </bold>This study aimed to evaluate the antibacterial efficacy of amikacin, cefotaxime, and meropenem impregnated into bone cement–based discs against Gram-negative bacteria <italic>Pseudomonas aeruginosa</italic> and <italic>Klebsiella pneumoniae</italic>.</p> <p><bold>METHODS: </bold>This was a single-center, continuous, prospective, non-blinded <italic>in vitro </italic>experimental study. Reference bacterial strains belonging to two taxonomic groups were used as test cultures: <italic>Pseudomonas</italic> <italic>aeruginosa</italic> ATCC 27853 and <italic>Klebsiella pneumonia</italic>e ATCC 700603. Discs with a diameter of 5 mm and a thickness of 2 mm were prepared from polymethyl methacrylate (PMMA)-based bone cement (Synicem 1). Antibiotics were incorporated into the cement in three weight proportions (groups 1, 2, and 3). The antibacterial effect of antibiotic-impregnated discs against the tested bacterial strains was assessed using the disk diffusion method. The experiment was conducted over six days. Results were recorded at 24, 48, 72, and 144 hours.</p> <p><bold>RESULTS:</bold> After 24 hours, bactericidal activity against <italic>P. aeruginosa</italic> strains was observed on Petri dishes containing discs impregnated with meropenem, amikacin, and cefotaxime. After 48 hours and during subsequent observation periods, a reduction in the diameter of bacterial growth inhibition zones was noted. For <italic>K. pneumoniae</italic> strains, no inhibition zone was observed when amikacin-impregnated bone cement was used in groups 1 and 2. A minimal antibacterial effect was observed with the use of discs in group 3. Discs containing cefotaxime exhibited weak antibacterial activity. Meropenem diffusion (groups 2 and 3) and bactericidal effects were observed throughout the entire 6-day period, with the most pronounced antibacterial activity occurring during the first 24 hours.</p> <p><bold>CONCLUSION: </bold>In experiments involving <italic>P. aeruginosa</italic>, all tested antibiotics demonstrated maximum release during the first 24 hours, regardless of their concentration in the discs. Subsequently, the elution rate decreased and remained stable until the end of the experiment. In experiments with <italic>K. pneumoniae</italic>, meropenem was the only effective antibiotic during the first day of observation. Among the antibiotics impregnated into PMMA-based discs, only meropenem demonstrated consistent antibacterial activity against both <italic>P. aeruginosa</italic> and <italic>K. pneumoniae</italic>, suggesting its potential use for local antibacterial therapy. Further <italic>in vitro</italic> and <italic>in vivo</italic> studies are required to determine the optimal antibiotic concentration and clinical efficacy in the prevention and treatment of chronic osteomyelitis.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование. </bold>На сегодняшний день существует необходимость в разработке новых композиций костных цементов с антибиотиками, в том числе эффективных против резистентных штаммов бактерий, которые позволяли бы создать локальную антибактериальную среду, способствующую подавлению роста и уничтожению патогенов, не вызывая токсических реакций.</p> <p><bold>Цель. </bold>Оценить эффективность амикацина, цефотаксима и меропенема, импрегнированных в диски на основе костного цемента, в отношении грамотрицательных бактерий <italic>Pseudomonas </italic><italic>aeruginosa</italic>, <italic>Klebsiella </italic><italic>pneumoniae</italic>.</p> <p><bold>Методы. </bold>Выполнено одноцентровое сплошное проспективное неослеплённое экспериментальное исследование <italic>in vitro</italic>. В качестве тест-культур использовали музейные штаммы бактерий, принадлежащих к двум таксономическим группам: <italic>Pseudomonas</italic> <italic>aeruginosa </italic>АТСС 27853, <italic>Klebsiella pneumoniae </italic>АТСС 700603. Из костного цемента (Synicem 1) на основе полиметилметакрилата (ПММА) изготовляли диски диаметром 5 мм и толщиной 2 мм, в цемент вносили антибиотики в трёх весовых пропорциях (группы 1, 2 и 3). Оценивали антибактериальный эффект дисков, импрегнированных антибиотиками, в отношении исследуемых штаммов бактерий диско-диффузионным методом. Эксперимент проводили в течение шести суток. Результаты фиксировали через 24, 48, 72 и 144 ч.</p> <p><bold>Результаты.</bold> Через сутки эксперимента на чашках Петри с дисками, импрегнированными меропенемом, амикацином и цефотаксимом, наблюдали бактерицидный эффект в отношении штаммов <italic>P</italic><italic>. </italic><italic>aeruginosa</italic>, через 48 ч и в последующие дни наблюдения отмечали уменьшение зоны подавления роста бактерий. В отношении штаммов <italic>K</italic><italic>. </italic><italic>pneumoniae</italic> отсутствовала зона задержки роста при использовании костного цемента, импрегнированного амикацином, в группах 1 и 2. Незначительный антибактериальный эффект отмечен при использовании дисков в группе 3. Диски с цефотаксимом оказывали слабое антибактериальное действие. Диффузию меропенема (группы 2 и 3) и бактерицидный эффект наблюдали в течение 6 суток, выраженное антибактериальное действие отмечалось в первые сутки.</p> <p><bold>Заключение. </bold>В опытах с <italic>P</italic><italic>. </italic><italic>aeruginosa</italic> для всех антибиотиков, независимо от их содержания в дисках, было характерно максимальное высвобождение в течение первых суток, затем скорость элюирования снижалась и оставалась постоянной до окончания эксперимента. В опытах с <italic>K</italic><italic>. </italic><italic>pneumoniae</italic> единственным эффективным препаратом в течение первых суток эксперимента был меропенем. Среди исследуемых препаратов, импрегнированных в диски с ПММА, эффективность против бактерий <italic>P</italic><italic>. </italic><italic>aeruginosa</italic> и <italic>K</italic><italic>. </italic><italic>pneumoniae</italic> продемонстрировал только меропенем, который может быть использован для локальной антибактериальной терапии. Дальнейшие исследования <italic>in vitro</italic> и <italic>in vivo</italic> необходимы для определения оптимальной концентрации антибиотика и клинической эффективности в профилактике и лечении хронического остеомиелита.</p></trans-abstract><kwd-group xml:lang="en"><kwd>chronic osteomyelitis</kwd><kwd>meropenem</kwd><kwd>cefotaxime</kwd><kwd>amikacin</kwd><kwd>bone cement</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>хронический остеомиелит</kwd><kwd>меропенем</kwd><kwd>цефотаксим</kwd><kwd>амикацин</kwd><kwd>костный цемент</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Правительство Российской Федерации</institution></institution-wrap><institution-wrap><institution xml:lang="en">Government of the Russian Federation</institution></institution-wrap></funding-source></award-group><funding-statement xml:lang="en">The study was conducted as part of a state-funded research project titled Development of Temporary Bioresorbable Antibacterial Carriers for the Reconstruction of Post-Osteomyelitic Defects of the Lower Limb Bones (2024–2026).</funding-statement><funding-statement xml:lang="ru">Работа выполнена в рамках темы государственного задания на осуществление научных исследований «Разработка временных биорезорбируемых антибактериальных носителей для замещения постостеомиелитических дефектов костей нижних конечностей» (2024–2026 гг.).</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Mironov SP, Tsiskarashvili AV, Gorbatyuk DS. Chronic post-traumatic osteomyelitis as a problem of modern traumatology and orthopedics (literature review). Genij ortopedii. 2019;25(4):610–621. doi: 10.18019/1028-4427-2019-25-4-610-621</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Schmitt SK. Osteomyelitis. Infect Dis Clin North Am. 2017;31(2):325–338. doi: 10.1016/j.idc.2017.01.010</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Shipitsyna IV, Osipova EV. Resistance of leading pathogens of chronic osteomyelitis. Clinical laboratory diagnostics. 2022;67(12):723–728. doi: 10.51620/0869-2084-2022-67-12-723-728 EDN: EHQEET</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Popkov AV, Shastov AL, Shipitsyna IV, et al. Bactericidal activity of experimental samples of titanium alloy implants with a calcium phosphate coating and an antibacterial component against gram-negative pathogens (experimental study). N.N. Priorov Journal of Traumatology and Ortopedics. 2024;31(4):517–526. doi: 10.17816/vto630216 EDN: ACGZAC</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Sukhorukova MV, Eidelshtein MV, Ivanchik NV, et al.; MARATHON research group. Antibiotic resistance of nosocomial Enterobacterales strains in Russian hospitals: results of the multicenter epidemiological study MARATHON 2015-2016. Clinical microbiology and antimicrobial chemotherapy. 2019;21(2):147–159. doi: 10.36488/cmac.2019.2.147-159 EDN: QDARVM</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Huang CY, Hsieh RW, Yen HT, et al. Short-versus long-course antibiotics in osteomyelitis: A systematic review and meta-analysis. Int J Antimicrob Agents. 2019;53(3):246–260. doi: 10.1016/j.ijantimicag.2019.01.007</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Cobb LH, McCabe EM, Priddy LB. Therapeutics and delivery vehicles for local treatment of osteomyelitis. J Orthop Res. 2020;38(10):2091–2103. doi: 10.1002/jor.24689</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Cara A, Ferry T, Laurent F, Josse J. Prophylactic antibiofilm activity of antibiotic-loaded bone cements against gram-negative bacteria. Antibiotics (Basel). 2022;11(2):137. doi: 10.3390/antibiotics11020137</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Mills DK, Jammalamadaka U, Tappa K, Weisman J. Studies on the cytocompatibility, mechanical and antimicrobial properties of 3D printed poly (methyl methacrylate) beads. Bioact. Mater. 2018;3(2):157–166. doi: 10.1016/j.bioactmat.2018.01.006</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Efremov IM, Midlenko VI. Studying strength characteristics of impregnated polymer composition for practical use in the field of purulent surgery. News of higher educational institutions. Volga region. Medical sciences. 2022;(2):83–91. doi: 10.21685/2072-3032-2022-2-9 EDN: BJNMYJ</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Zhang J, Feng Y, Zhou X, et al. Research status of artificial bone materials. International Journal of Polymeric Materials and Polymeric Biomaterials. 2021;70(1):37–53. doi: 10.1080/00914037.2019.1685518</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Liu Y, He L, Cheng L, et al. Enhancing bone grafting outcomes: a comprehensive review of antibacterial artificial composite bone scaffolds. Med Sci Monit. 2023;29:e939972. doi: 10.12659/MSM.939972</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Goldberg MA, Smirnov VV, Krokhicheva PA, et al. Prospects of development and application of calcium and magnesium phosphate bone cements with antimicrobial properties (review). Materials Science. 2020;(7):39–47. doi: 10.31044/1684-579X-2020-0-7-39-47 EDN: IJTYTM</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Melikova RE, Tsiskarashvili AV. Local antibacterial depot systems in the treatment of bone and joint infection (literature review). N.N. Priorov Journal of Traumatology and Ortopedics. 2024;31(4):677–695. doi: 10.17816/vto632032 EDN: ILAUXQ</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Castaneda P, McLaren A, Tavaziva G, Overstreet D. Biofilm antimicrobial susceptibility increases with antimicrobial exposure time. Clin Orthop Relat Res. 2016;474(7):1659–64. doi: 10.1007/s11999-016-4700-z</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Chen X, Thomsen TR, Winkler H, Xu Y. Influence of biofilm growth age, media, antibiotic concentration and exposure time on Staphylococcus aureus and Pseudomonas aeruginosa biofilm removal in vitro. BMC Microbiol. 2020;24;20(1):264. doi: 10.1186/s12866-020-01947-9</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Chen IC, Su CY, Nien WH, et al. Influence of antibiotic-loaded acrylic bone cement composition on drug release behavior and mechanism. Polymers (Basel). 2021;13(14):2240. doi: 10.3390/polym13142240</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Shipitsyna IV, Osipova EV, Leonchuk DS, Sudnitsyn AS. Monitoring of the leading gradual microflora and antibiotic resistance in osteomyelitis. Genij ortopedii. 2020;26(4):544–7. doi: 10.18019/1028-4427-2020-26-4-544-547 EDN: EKBOTN</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Inzana JA, Schwarz EM, Kates SL, Awad HA. Biomaterials approaches to treating implant-associated osteomyelitis. Biomaterials. 2016;81:58–71. doi: 10.1016/J.biomaterials.2015.12.012</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Wassif RK, Elkayal M, Shamma RN, Elkheshen SA. Recent advances in the local antibiotics delivery systems for management of osteomyelitis. Drug Deliv. 2021;28(1):2392–2414. doi: 10.1080/10717544.2021.1998246</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Suhardi VJ, Bichara DA, Kwok S, et al. A fully functional drug-eluting joint implant. Nat Biomed Eng. 2017;1:0080. doi: 10.1038/s41551-017-0080</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Levack AE, Turajane K, Yang X, et al. Thermal stability and in vitro elution kinetics of alternative antibiotics in polymethylmethacrylate (PMMA) bone cement. J Bone Joint Surg Am. 2021;103(18):1694–1704. doi: 10.2106/JBJS.20.00011</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Shafigulin RA, Akhtyamov IF, Emelin AL, et al. Elution of antibiotics from bone cement: problems and ways to solution. Genij Ortopedii. 2025;31(1):119–128. doi: 10.18019/1028-4427-2025-31-1-119-128 EDN: BBNLYW</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Stogov MV, Shastov AL, Kireeva EA, Tushina NV. Release of antibiotics from materials for replacing post-osteomyelitic bone defects. Genij ortopedii. 2024;30(6):873–880. doi: 10.18019/1028-4427-2024-30-6-873-880 EDN: UIOYYM</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Dusanea DH, Diamondb SM, Knechtb CS, et al. Effects of loading concentration, blood and synovial fluid on antibiotic release and anti-biofilm activity of bone cement beads. J Control Release. 2017;248:24–32. doi: 10.1016/j.jconrel.2017.01.005</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Slane J, Gietman B, Squire M. Antibiotic elution from acrylic bone cement loaded with high doses of tobramycin and vancomycin. J Orthop Res. 2018;36(4):1078–1085. doi: 10.1002/jor.23722</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Meeker DG, Cooper KB, Renard RL, et al. Сomparative study of antibiotic elution profiles from alternative formulations of polymethylmethacrylate bone cement. J Arthroplast. 2019;34(7):1458–1461. doi: 10.1016/j.arth.2019.03.008</mixed-citation></ref></ref-list></back></article>
